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ABSTRACT
Telomerase is a ribonucleoprotein that adds DNA
to the ends of chromosomes. The catalytic protein
subunit of telomerase (TERT) contains an N-terminal
domain (TEN) that is important for activity and
processivity. Here we describe a mutation in the
TEN domain of human TERT that results in a
greatly increased primer Kd, supporting a role for
the TEN domain in DNA affinity. Measurement of
enzyme kinetic parameters has revealed that this
mutant enzyme is also defective in dNTP polymer-
ization, particularly while copying position 51 of the
RNA template. The catalytic defect is independent
of the presence of binding interactions at the
50-region of the DNA primer, and is not a defect in
translocation rate. These data suggest that the TEN
domain is involved in conformational changes
required to position the 30-end of the primer in the
active site during nucleotide addition, a function
which is distinct from the role of the TEN domain
in providing DNA binding affinity.
INTRODUCTION
Telomeres, the protective cap on the end of linear eukary-
otic chromosomes, are composed of short G-rich DNA
repeats bound by sequence-speciﬁc proteins (1). The telo-
meres of unicellular eukaryotes and of the germ cells of
multicellular organisms are maintained by the
ribonucleoprotein enzyme telomerase, which was ﬁrst
identiﬁed in the ciliated protozoan Tetrahymena
thermophila (2). Telomerase activity has been detected
in  90% of human cancers, providing a telomere
maintenance mechanism that is necessary for their unlim-
ited growth (3–5).
The catalytic protein subunit of telomerase, telomerase
reverse transcriptase [TERT (6)], contains protein motifs
that are conserved with other reverse transcriptases (‘RT
motifs’) and motifs in its amino terminal region that are
conserved among TERTs from different species. A deﬁned
region of the telomerase RNA subunit is used as the
template for addition of DNA repeats onto telomeres
(7). A complex consisting of TERT and telomerase
RNA is sufﬁcient to reconstitute in vitro telomerase
activity from Tetrahymena and human enzymes,
measured by processive extension of a DNA oligonucleo-
tide with telomeric DNA repeats (8,9). The repeated
cycling of reverse transcription from a short segment of
RNA, followed by translocation to the beginning of this
sequence, leads to the unique property of telomerase
known as ‘repeat addition processivity’.
There is evidence for telomerase from several species
that there are multiple sites of interaction with different
regions of the DNA primer. For example, the afﬁnity of
Tetrahymena telomerase for DNA decreased in a stepwise
manner as the primer was reduced in length from 18 to
12nt then 6nt (10,11), and two 50-regions of a 24nt primer
inﬂuenced yeast telomerase activity (12). Sequences at the
50-end of the primer also affected the processivity of en-
dogenous human and Tetrahymena telomerase (13,14).
These observations led to the proposal that telomerase
contains a DNA-binding site outside the template
region, called the ‘anchor site’ (13–15). It was proposed
that the anchor site is necessary for repeat addition
processivity, by allowing the enzyme to remain bound to
the 50-end of its DNA substrate during translocation.
Thus, in order to fully understand the unique mechanism
of telomerase, it is necessary to know more about the
nature of the anchor site.
*To whom correspondence should be addressed. Tel: +61 2 8865 2909; Fax: +61 2 9687 2120; Email: tbryan@cmri.org.au
Present address:
Amanda S. Nouwens, School of Chemistry and Molecular Biosciences, University of Queensland, QLD 4072, Australia.
1774–1788 Nucleic Acids Research, 2011, Vol. 39, No. 5 Published online 3 November 2010
doi:10.1093/nar/gkq1083
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The N-terminal 200 amino acids of TERT [known
as region I (16) or the GQ (17), RID1 (18) or TEN
(19) domain] have been proposed as a key contributor
to the telomerase anchor site. This region of TERT has
the ability to form a soluble, protease-resistant,
independently-folded structure (17,19–21). Complemen-
tation studies with fragments of human TERT indicate
that this region (together with an adjacent linker
domain) can interact in trans with the rest of the TERT
protein (18,22–24). Activity-based assays have provided
support for anchor site functions (25–27). Direct
evidence for the involvement of this region in DNA
binding was provided by the demonstration that muta-
tions in Tetrahymena TEN led to decreased crosslinking
to a primer containing 5-iodo-deoxyuridine (5-iodo-dU)
substitutions at its 50-end (19), and the site of crosslinking
to a short primer was mapped to a particular amino acid
within TEN (W187) (28). Direct binding assays (using
capture with a biotinylated primer or gel shift analysis)
have demonstrated that a fragment of human TERT
encompassing TEN can bind telomeric DNA primers
(24,29,30).
The exact role of the TEN domain in DNA binding,
however, remains uncertain. Its afﬁnity for DNA
appears to be relatively low compared to other regions
of TERT (11); a recent study using a bacterially-expressed
TEN fragment of hTERT in gel shift analyses was unable
to produce enough protein to quantitatively measure
DNA afﬁnity (24), implying a low-afﬁnity interaction.
Also, amino acids in TEN critical for repeat addition
processivity or activity (L14 in Tetrahymena TERT and
Q169 in hTERT, respectively) have been shown to not
affect afﬁnity with DNA of the same length as used in
the activity assays (24,31). However, the amino acid cor-
responding to Q169 in Tetrahymena TERT (Q168) is
involved in crosslinking to DNA (19); it is not clear if
this discrepancy is due to a species difference or a differ-
ence in assays used to measure binding.
Given this uncertainty, we set out to quantitatively
examine the effect on DNA binding of mutations in the
hTERT TEN domain. We also examined the same muta-
tions using activity assays, carrying out a detailed analysis
of telomerase kinetic parameters in order to deﬁne the
reason for reduced activity. Our data suggest that amino
acids within the TEN domain are involved in positioning
the 30-end of the primer in the active site during nucleotide
addition, a function which is distinct from the role of the
TEN domain in providing DNA binding afﬁnity.
MATERIALS AND METHODS
Plasmids and oligonucleotides
A panel of hTERT mutants with substitutions of the
sequence NAAIRS and an N-terminal FLAG tag in the
retroviral vector pBabehygro was kindly provided by
Dr Christopher Counter, Duke University Medical
Centre, Durham, NC (32). To create plasmids for
in vitro expression, selected mutants were digested with
EcoRI/SalI and the FLAG-hTERT fragment was
sub-cloned into EcoRI/SalI sites of the pET-28 plasmid
(Invitrogen). After carrying out many of the experiments
in this study, we discovered two variations in the hTERT
sequence in the NAAIRS panel compared to the hTERT
sequence in Genbank entry AF015950 (33–35). These
hTERT sequence changes (S229T and D516G) were cor-
rected in the wild-type (wt) and mutant +170 expression
constructs using the QuikChange II XL site-directed mu-
tagenesis kit (Stratagene). There was no signiﬁcant differ-
ence between these sequence variants in any of the in vitro
kinetic parameters measured in this study (Supplementary
Table S1 and Figure S2).
To construct a plasmid for in vitro transcription of hTR,
the hTR gene [nucleotides 1–592] was ampliﬁed by PCR
(36) and inserted into the vector pGEM-T (Promega). The
insert of this plasmid was reampliﬁed using primers that
covered the 451 nt of hTR and included a T7 promoter
(50-end, for transcription) and a FokI restriction sequence
(30-end, for plasmid linearization) and inserted into the
EcoRI/BamHI sites of plasmid pUC19. Linearization of
the plasmid with FokI results in a transcription product
terminating at the hTR 30-end.
All oligonucleotides used for this study (listed in
Table 1) were purchased from Sigma-Genosys in
desalted lyophilized form and were gel puriﬁed on 20%
acrylamide/8M urea gels before use. Puriﬁed oligonucleo-
tides were resuspended in 10mM Tris–Cl, pH 7.5.
In vitro translation and reconstitution of human
telomerase
Human telomerase RNA was transcribed in vitro from the
plasmid pUC-hTR as described earlier (37). The RNA was
gel puriﬁed and quantitated by absorbance at 260nm
before use in in vitro translation reactions using the
FLAG-hTERT-pET-28 plasmids described above.
Translations were carried out using the TnT Quick for
PCR rabbit reticulocyte lysate system (Promega).
Recombinant enzyme reconstitution reactions (400ml)
contained 320ml TnT Quick mastermix, 8mg of plasmid
encoding the protein, 32mlo f[
35S]methionine
(Perkin-Elmer; 1175Ci/mmol, 10mCi/ml) and 150nM
telomerase RNA and were incubated at 30 C for 1h.
Reconstituted enzyme was immunopuriﬁed with
anti-FLAG M2 afﬁnity agarose beads (Sigma-Aldrich)
in Protein LoBind tubes (Eppendorf). Beads (200ml 1:1
slurry) were initially washed four times in 880ml of Tris–
IP buffer [10mM Tris–Cl, pH 7.5, 100mM KCl, 1mM
MgCl2, 10% glycerol and 0.1mM dithiothreitol (DTT)],
centrifuging at 1000g for 2min at 4 C between washes.
The translation reaction was diluted 1:10 in Tris–IP
buffer. The washed anti-FLAG beads were added and
the sample rotated at 12rpm at 4 C for 2h. The beads
were washed four times in 4ml of hTel buffer (50mM
Tris–Cl, pH 8.0, 1mM MgCl2, 100mM KCl, 5mM
DTT, 1mM spermidine and 10% glycerol) before telomer-
ase was eluted from the beads by competition with a 3 
FLAG peptide (Sigma-Aldrich). The beads were resus-
pended in 120ml of an elution mix (0.75mg/ml FLAG
peptide, 0.5mg/ml BSA in hTel buffer) and rotated at
4 C for 1h, centrifuged at 1000g for 2min at 4 C and
the eluate removed to a fresh LoBind tube.
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blotting using a probe against hTR. Aliquots of the
immunopuriﬁed enzyme in formamide loading buffer
(90% deionized formamide, 0.1% bromophenol blue,
0.1% xylene cyanol, in 1  TBE (89mM Tris, 89mM
Boric acid, 2mM EDTA)) were heated to 70 C for
10min and chilled on ice for 2min. The samples were
dotted onto Hybond N+ membrane (GE Healthcare).
The membrane was air dried for 1h at RT, cross-linked
with 254nm UV light using the autocrosslink function of
the Stratalinker cross-linker (Stratagene) and
pre-hybridized in Church buffer [1% BSA (Fraction V
grade, Roche), 1mM EDTA, pH 7.5, 500mM
Na2HPO4, pH 7.2, 7% SDS] for 1h at 55 C. The blot
was hybridized in Church buffer overnight at 55 C with
1 10
7cpm of
32P end-labelled Telo4 probe directed
against hTR (Table 1). The membrane was washed three
times for 10min in wash buffer (15mM NaCl, 1.5mM
Tri-sodium citrate, 0.1% SDS) at RT, sealed in a plastic
bag, exposed to a phosphorimager screen overnight,
scanned with a Typhoon 9410 Workstation (GE
Healthcare) and quantitated with ImageQuant software
(Molecular Dynamics). Aliquots of puriﬁed recombinant
enzyme were added to an equal volume of 5  Laemmli’s
sample buffer (250mM Tris–Cl, pH 6.8, 10% SDS,
0.01% bromophenol blue, 50% glycerol, 1.8M
b-mercaptoethanol) and were also subjected to SDS–
PAGE analysis in order to normalize yield of RNA to
yield of hTERT. Samples were heated to 100 C for
3min and electrophoresed on an 8% polyacrylamide/
SDS gel. The gel was ﬁxed in 25% isopropyl alcohol,
10% acetic acid, 20% glycerol for 30min, dried at 80 C
for 1h and exposed to a phosphorimager screen overnight.
Cell culture and plasmid transfection
WI-38 VA13/2RA human foetal ﬁbroblasts (ATCC) and
human embryonic kidney (HEK) cell line 293T were
cultured in Dulbeco’s Modiﬁed Eagles Medium
(Invitrogen) supplemented with 10% foetal calf serum
(Sigma) and grown in a 37 C humidiﬁed incubator
containing 5% CO2.
WI-38 VA13/2RA and 293T cells were co-transfected
with plasmids encoding hTERT under a CMV promoter
(38) and hTR under a U3 promoter (39) using Fugene-6
transfection reagent (Roche) and incubated at 37 C for
6h. After 72h at 32 C the cells were harvested and lysed
in 1ml of buffer A per 10
7 cells (20mM HEPES–KOH,
pH 7.9, 300mM KCl, 2mM MgCl2, 10% glycerol, 1mM
EDTA, 0.1% Triton X-100, 1mM DTT and 1mM
PMSF). The cell suspensions were rotated at 4 C for 1h
and centrifuged at 18 000g at 4 C for 20min to clarify the
lysate. The supernatant was transferred to a Protein
LoBind microfuge tube (Eppendorf), snap frozen in
liquid nitrogen and stored at  80 C.
Immunopuriﬁcation of overexpressed or endogenous
telomerase
Lysates of telomerase-transfected WI-38 VA13/2RA or
293T cells (10
7 cells in 1ml; described above) or
untransfected 293 cells (5 10
7 cells in 1ml) were
incubated with 20mg sheep polyclonal anti-hTERT
antibody (40) for 1h at 4 C. Protein G agarose beads
(50ml) were pre-blocked in buffer A+BSA (0.5mg/ml)
for 30min at RT, added to the sample and rotated for
1h at 4 C. The remaining steps of the protocol were con-
ducted in a 4 C coldroom with ice-cold buffers. Samples
were transferred into Illustra Micropsin columns (GE
Healthcare) attached to a vacuum manifold and were
washed with 10ml of buffer A followed by 5ml of hTel
buffer (50mM Tris–Cl, pH 8.0, 1mM MgCl2, 100mM
KCl, 5mM DTT, 1mM spermidine, 10% glycerol). To
elute the puriﬁed protein, 300ml of hTel buffer containing
50mM peptide antigen (40) was added to the plugged
column and rotated at RT for 1h. The microspin
column was unplugged and centrifuged at 1000g for
1min at RT to collect the enzyme into a Protein LoBind
tube (Eppendorf). Puriﬁed enzyme was snap frozen in
liquid nitrogen and stored at  80 C. The yield of active
enzyme was determined by dot blotting using a probe
against hTR, as described above.
Telomerase activity assays
Telomerase activity was measured by incubating 10mlo f
immunopuriﬁed telomerase (recombinant, endogenous or
overexpressed) in a 20ml reaction including 50mM Tris–
Cl, pH 8.0, 1mM MgCl2, 50mM KCl, 5mM DTT, 1mM
spermidine, 10% glycerol, 0.5mM dTTP, 0.5mM dATP,
4.6mM nonradioactive dGTP and 0.33mM[ a-
32P]dGTP at
20mCi/ml, 6000Ci/mmol (PerkinElmer Life Sciences).
The indicated DNA primers were added to the reactions
at concentrations of 10nM to 5mM. Standard primer con-
centrations were 1–2mM for 18-nt primers, 5mM for 9-nt
primers and 50mM for 5nt primers. The reactions were
incubated at 30 C for 1–6h; the linear phase of enzyme
activity extends for  10h (data not shown). Reactions
were terminated by addition of 100ml of TES buffer
(50mM Tris–Cl, pH 8.3, 20mM EDTA, 0.2% SDS);
1000cpm of a
32P end-labelled 100-nt oligonucleotide
Table 1. Oligonucleotides used in this study
Name Sequence
18GGG TTAGGGTTAGGGTTAGGG
18GGT TAGGGTTAGGGTTAGGGT
18GTT AGGGTTAGGGTTAGGGTT
18TTA GGGTTAGGGTTAGGGTTA
18TAG GGTTAGGGTTAGGGTTAG
18AGG GTTAGGGTTAGGGTTAGG
18ACT GGTTAGGGTTAACTTTAG
9GGG GGGTTAGGG
5TTA GGTTA
5GGT AGGGT
Bio-18GGG Biotin-CTAGACCTGTCATCATTAGGGTTAGGG
TTAGGG
Bio-18TAG Biotin-CTAGACCTGTCATCAGGTTAGGGTTAG
GGTTAG
Bio-12GGG Biotin-CTAGACCTGTCATCATTAGGGTTAGGG
Bio-PBR Biotin-AGCCACTATCGACTACGCGATCAT
Telo4 CGGTGGAAGGCGGCAGGCCGAGGC
All sequences are listed 50–30.
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products were phenol/chloroform extracted and ethanol
precipitated. The pellet was resuspended in 5mlo fT E
buffer and 5ml of formamide loading buffer (90%
deionised formamide, 0.1% bromophenol blue, 0.1%
xylene cyanol in 1  TBE). Immediately prior to gel
loading, samples were heated to 70 C for 5min and
chilled on ice for 2min before centrifuging at 16000g at
4 C for 2min. Half the reaction was electrophoresed on a
denaturing 10% polyacrylamide/8M urea sequencing gel
for 2h at 80 W. The gel was dried at 80 C for 30min,
exposed to a phosphorimager screen, scanned with a
Typhoon 9410 Workstation and quantitated with
ImageQuant software.
For experiments using a single nucleotide, the concen-
trations of nucleotide were 47.5mM non-radioactive dTTP
and 2.5mM[ a-
32P] dTTP at 10mCi/ml, 800Ci/mmol (for
‘T-only’ assays), 47.5mM non-radioactive dATP and
2.5mM[ a-
32P] dATP at 10mCi/ml, 800Ci/mmol (for
‘A-only’ assays) and 10mM non-radioactive dGTP and
0.66mM[ a-
32P] dGTP at 20mCi/ml, 6000Ci/mmol
(for ‘G-only’ reactions). These concentrations are above
the approximate Km of wt recombinant telomerase for
each nucleotide [8mM for dTTP, 1mM for dATP (data
not shown) and 1.3mM for dGTP]. Experiments
measuring the afﬁnity of dGTP included 0.5mM dTTP,
0.5mM dATP and the indicated concentration of dGTP
at a constant speciﬁc activity of 200Ci/mmol.
The intensity of extension products at each substrate
concentration was summed and normalized against the
intensity of the
32P-labelled 100-nt oligonucleotide
loading control to give relative activities; those in
Figure 1c were carried out at 1mM substrate. These data
were then expressed as a percentage of the reaction
with maximal activity and plotted against oligonucleotide
(substrate) concentration [S]. The curve was ﬁtted to
the equation y=(Vmax [S])/(Km+[S]), to yield the
Michealis–Menton afﬁnity constant Km. To calculate
relative processivity, the intensity of the ﬁrst 3–5 repeats
was adjusted for speciﬁc activity (i.e. number of
incorporated radiolabelled nucleotides per repeat) and
plotted versus repeat number on a log-linear graph.
Processivity was deﬁned as  0.693/s, where s is the slope
of the resulting straight line.
For calculating kobs, gels such as that in Figure 6b
included a standard curve of known amounts (cpm) of a
32P-labelled 100-nt oligonucleotide. The cpm of each tel-
omerase product band were converted to Ci (since
1cpm=2.2 10
 12Ci for
32P), then to fmol based on
the speciﬁc activity of the radiolabelled nucleotides,
and normalized to the fmol of enzyme used in the assay
to give kobs.
DNA binding assay to measure primer binding to hTERT
Ultralink Immobilized NeutrAvidin Protein Plus beads
(Thermo Scientiﬁc) (700ml) were washed four times in
1ml wash buffer 75 (50mM Tris–Cl, pH 8.0, 1mM
MgCl2, 10% glycerol, 75mM KCl, 5mM DTT, 1mM
spermidine), centrifuging at 1000g for 1min at 4 C
between washes. The beads were incubated twice with
1ml of blocking buffer (50mM Tris–Cl, pH 8.0, 1mM
MgCl2, 10% glycerol, 75mM KCl, 5mM DTT, 1mM
spermidine, 0.75mg/ml BSA, 0.15mg/ml glycogen) for
30min at RT with agitation and resuspended in 350ml
blocking buffer (for 293T telomerase) or hTel buffer (for
recombinant telomerase). Immunopuriﬁed overexpressed
telomerase from 293T cells (50ml) or immunopuriﬁed re-
combinant telomerase (10ml) was added to a 100ml
reaction including hTel buffer (50mM Tris–Cl, pH 8.0,
1mM MgCl2, 50mM KCl, 5mM DTT, 1mM spermidine,
10% glycerol) and oligonucleotide at concentrations
ranging from 0 to 10mM. Similar results were obtained
with telomerase expressed in 293T cells or WI-38 VA13/
2RA cells (data not shown). The reactions were incubated
at 30 C for 30min (293T telomerase) or 60min (recom-
binant telomerase) followed by the addition of 50mlo f
blocked NeutrAvidin beads and agitation at 4 C for 2h.
The samples were washed three times in 300ml of wash
buffer 50 (50mM Tris–Cl, pH 8.0, 1mM MgCl2, 10%
glycerol, 50mM KCl, 5mM DTT, 1mM spermidine)
with centrifugation at 1000g for 2min at 4 C between
washes, before the bead pellets were resuspended in
100ml of formamide loading buffer (see above) containing
0.5mM biotin. Immediately prior to dot blotting, the
samples were heated to 70 C for 10min, chilled on ice
for 2min and centrifuged at 14000g for 1min at 4 C.
Half of the reaction was dotted onto Hybond N+
membrane alongside in vitro transcribed hTR standards
loaded in an equal volume of formamide loading buffer.
The membrane was probed with
32P end-labelled Telo4
probe against hTR, as described above. The blot was
exposed to a phosphorimager screen for 72h and
analysed using ImageQuant TL software. The signal
from the sample blank (containing no oligonucleotide)
representing background binding to the beads
was substracted from all others. The resulting value
was expressed as a percentage of the maximal inten-
sity at the highest primer concentration and plotted
against oligonucleotide (substrate) concentration [S].
The curve was ﬁtted to the following equation:
y=(Bmax [S])(Kd+[S]), where Bmax is the maximal
level of binding, to yield the dissociation constant Kd.
Glycerol density gradient centrifugation and fractionation
Glycerol gradient stock solutions containing either 10 or
40% glycerol in 300mM KCl, 2mM MgCl2, 0.1% Triton
X-100, 1mM DTT and 20mM HEPES–KOH pH 7.9
were combined using a two-chamber gradient mixer to
pour 11ml of 10–40% linear glycerol density gradients
in Ultra-Clear 13.2ml centrifuge tubes (14 89mm;
Beckman Coulter). Recombinant wild type or +170
mutant telomerase (500ml), synthesized in rabbit reticulo-
cyte lysate as described above, was applied to the top of
the gradient. Centrifugation was performed with a SW-41
Ti swinging-bucket rotor (Beckmann Coulter) at 230000g
at 4 C for 24h. Following centrifugation, glycerol gradi-
ents were collected by puncturing the base of each tube
with a 30-gauge needle; 23 0.5ml fractions were collected
by gravity elution and stored at  80 C. Telomerase
activity was measured using 27ml of each glycerol
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Bio-18GGG, as described above.
Northern blotting
Puriﬁed telomerase (from 5 10
6 telomerase-transfected
WI-38 VA13/2RA cells) in 300ml buffer A was digested
with 33ml Proteinase K buffer (100mM Tris–Cl, pH 7.5,
75mM EDTA, 6% SDS) and 2ml proteinase K (40mg) for
2h at 45 C. The samples were spiked with 5000 cpm of a
32P-labelled 100-nt oligonucleotide as a recovery and
loading control, phenol/chloroform extracted and
ethanol precipitated. The pellet was resuspended in 10ml
of MilliQ water and 10ml formamide loading buffer (90%
deionized formamide, 0.1% bromophenol blue, 0.1%
xylene cyanol in 1  TBE). Samples were heated at 70 C
for 5min, cooled on ice for 2min and electrophoresed on a
1.5-mm-thick 4% polyacrylamide, 8 M urea, 1  TBE gel
for 1h at 25 W in 1  TBE buffer. The gel was transferred
onto Hybond XL membrane (GE Healthcare) by
electroblotting for 2h at 1.5 A in 0.5  TBE buffer
cooled to 4 C with a recirculating water bath. The
membrane was probed with
32P end-labelled Telo4 probe
directed against hTR, as described above.
Western blotting
Puriﬁed telomerase (from 5 10
6 telomerase-transfected
WI-38 VA13/2RA or 293T cells) was added to an equal
volume of 5  Laemmli’s sample buffer (250mM Tris–Cl,
pH 6.8, 10% SDS, 0.01% bromophenol blue, 50%
glycerol and 1.8 M b-mercaptoethanol) and heated to
95 C for 5min. The samples were electrophoresed on an
8% polyacrylamide/SDS-PAGE gel in Laemmli’s running
buffer (25mM Tris, 0.1% SDS, 192mM glycine) for 2h at
100V and transferred to Hybond enhanced chemilumin-
escent (ECL) nitrocellulose (GE healthcare) by
electroblotting in Transfer buffer (25mM Tris, 0.01%
SDS, 192mM glycine) at 0.5A for 1h. The membrane
was blocked for 1h at RT in phosphate buffered saline
(PBS) containing 2% skim milk and 0.05% Tween-20.
The membrane was then incubated with primary
antibody [goat polyclonal anti-hTERT (sc7215); Santa
Cruz Biotechnology] diluted 1:1000 in PBS containing
1% skim milk and 0.05% Tween-20 overnight at 4 C.
The membrane was washed for 1h in several changes of
PBS/0.05% Tween-20 at RT followed by incubation for
1h at RT with the secondary antibody (rabbit anti-goat
immunoglobulin horseradish peroxidase; DAKO) diluted
1:10 000 in 1  PBS containing 1% skim milk and 0.05%
Tween-20. The membrane was rinsed with PBS before in-
cubation with Amersham ECL plus Western blotting de-
tection reagent (GE Healthcare) for 5min at RT. The blot
was exposed to a LASS-4000 Luminescent Image
Analyser (FujiFilm) and quantitated using Multigauge
software.
Protein homology modelling and nucleic acid docking
An homology model of the human hTERT TEN domain
was determined by threading the TEN domain sequence of
hTERT onto chain A of the Tetrahymena TEN domain
crystal structure [PDB id:2B2A (19)] using the
Bioinformatics Online Toolkit (http://toolkit.tuebingen.
mpg.de). A 3D homology model was then constructed
with MODELLER (http://www.salilab.org/modeller)
and the top-ranked model minimized using the Tripos
force ﬁeld until a gradient consensus was reached (21003
iterations, energy= 615.496 kcals/mol) followed by
minimization using the Kollman-all atom force ﬁeld,
with the addition of AMBER charges until a gradient
consensus was reached (16957 iterations, energy=
 2648.889kcal/mol). The stereochemical quality of the
model was checked with PROCHECK V3.5, with 96.9%
of residues in an acceptable region of a Ramachandran
plot and all other stereochemical statistics deemed reason-
able (41).
The DNA primer 50-TTA-30 was constructed in
Sybyl-X-1.1 using the Biopolymer module (http://www
.tripos.com). The DNA single strand was docked into
the TEN domain model using the HEX program [(42)
and http://www.csd.abdn.ac.uk/hex/]. A shape and elec-
trostatics correlation was used in the 3D Fastlite mode
with a grid dimension of 0.75A ˚ , receptor and ligand
range 180 , twist range 360 , distance range 40A ˚ and a
scan step of 0.75. Two thousand solutions were requested
in the initial dock with 20 clusters of solutions found after
post-minimization. The complementary RNA base pairs
(50-UAA-30) were added to the lowest energy dock and
visually analyzed.
RESULTS
A mutant of the hTERT TEN domain with reduced
activity and processivity, and dramatically increased
primer Km
To quantitate the contribution of human TEN to telomer-
ase activity and DNA afﬁnity, we performed in vitro
assays with a panel of hTERT mutants with six amino
acid substitutions of the sequence NAAIRS (32,43). This
substitution is predicted to have minimal effect on protein
structure (44). Telomerase was reconstituted in rabbit re-
ticulocyte lysates (RRL) using hTERT substituted with
NAAIRS at one of ﬁfteen positions throughout the
protein (Figure 1a), and activity measured with a direct
(i.e. non-PCR) assay using oligonucleotide 18GGG [(TTA
GGG)3] as a substrate (Figure 1b; see Table 1 for oligo-
nucleotide sequences). Relative activity levels were
quantitated based on total product intensity, and repeat
addition processivity (RAP) was determined from the rate
of decrease of product intensity over the ﬁrst three to ﬁve
repeats (Figure 1c). As a ﬁrst step towards examining
DNA afﬁnity, the Km for primer 18GGG was measured
by quantitating product intensity at different concentra-
tions of this primer (Figure 1c).
Activity levels of most NAAIRS mutants reﬂected those
measured using in vivo reconstituted telomerase (32,43).
One exception is the mutation at amino acids 8–13 (here-
after called +8 in line with the previous nomenclature),
which was substantially more active when reconstituted
in vitro than in vivo. This may be explained by the obser-
vation that the extreme N-terminus of hTERT is involved
in its nucleolar localization in vivo (45).
1778 Nucleic Acids Research, 2011,Vol.39, No. 5A subregion of the TEN domain has been shown to be
necessary for telomere extension in vivo but not telomerase
activity, and has been called the dissociates activities of
telomerase (DAT) domain (32). Mutations in the DAT
domain (Figure 1, purple) had modest effects on activity
and no reduction in RAP. Regions on either side of DAT
(regions 1A and 1B) were much more important for
activity. The 1B mutant (+170) had substantially
reduced RAP, while the 1A mutants (+8, +26) had wt
RAP. A mutation in the non-conserved linker region
(+200) had no effect on activity or RAP, while the
conserved motifs QFP and E [involved in RNA and
DNA binding respectively (18,29)] were essential for
activity. We conﬁrmed that mutations in the hTERT
C-terminus reduced both activity and RAP, as previously
shown (43,46).
Analysis of the Km for primer 18GGG gave unexpected
results. Mutants +26, +74 and +92 showed very modest
( 2-fold) increases in Km, while the Km of most other
mutants did not differ from wt. The one exception was
mutant +170 in region 1B, which had a dramatic
( 14-fold) increase in Km (Figure 1c, Table 2).
Primers with different permutations of the 30-end have
up to 100-fold differences in dissociation rate from en-
dogenous human telomerase (47), accounting for the dis-
tinctive 6nt pausing pattern of telomerase extension. Since
the pausing pattern of recombinant human telomerase is
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Figure 1. A mutant of the hTERT TEN domain with reduced activity and processivity, and dramatically increased primer Km.( a) Schematic of the
domain structure of hTERT, showing locations of the telomerase essential N-terminal domain (TEN), RNA binding domain (RBD), reverse
transcriptase domain (RT) and C-terminal domain (C-term). Coloured boxes indicate conserved sequence motifs. Dots beneath the protein
indicate locations of the ﬁfteen NAAIRS substitutions examined in this study. (b) Direct telomerase activity assay of NAAIRS substituted telomerase
reconstituted in rabbit reticulocyte lysates, and endogenous telomerase from 293 cells (‘end’). LC: labelled 100nt oligonucleotide as a recovery and
loading control; +4: position of primer (18GGG) with the addition of 4nt. (c) Quantitation of the relative activity, repeat addition processivity
(RAP) and primer Km (for 18GGG) of the panel of NAAIRS mutants. Values are the mean±standard deviation of three independent experiments.
Table 2. Km of various DNA primers with wt recombinant hTERT
and mutant +170, and the fold difference between these numbers
Primer Sequence Km (nM)
wt +170 Fold
difference
Endogenous
wt
18GGG (TTAGGG)3 49±29 710±140 14 7.8±0.3
18TTA (GGGTTA)3 65±4 1530±100 24 9.7±5.6
9GGG GGGTTAGGG 56±16 300±20 5 n.d.
The right column lists the Km of some of the same primers for endogen-
ous wt human telomerase. Results are the mean±standard deviation
of two to six experiments.
n.d., not determined.
Nucleic Acids Research,2011, Vol.39, No. 5 1779very similar to that of endogenous telomerase puriﬁed
from 293 cell extracts (Supplementary Figure S1), it is
highly likely that recombinant telomerase shows the
same pattern of dissociation at different template pos-
itions. We therefore also measured the Km of the primer
18TTA [(GGGTTA)3]; see Figure 6a for an illustration of
the alignment of this primer with the RNA template
relative to that of primer 18GGG. Mutant +170 showed
an even greater increase in Km with primer 18TTA
(Table 2 and Supplementary Figure S1). For wt telomer-
ase the Km for primers 18GGG and 18TTA were not sub-
stantially different (Table 2); since these primers are
predicted to have a  100-fold difference in dissociation
rate, this implies that Km may not be a good reﬂection
of primer afﬁnity (Kd) for telomerase. This is also the
case for endogenous human telomerase from 293 cells;
the Kms of 18GGG and 18TTA were lower for endogen-
ous telomerase than recombinant, but were similar to each
other (Table 2). We therefore embarked on an exploration
of the kinetic parameters of mutant +170 telomerase in
order to identify the defect(s) responsible for its
dramatic Km increase.
During the course of this study, we detected two add-
itional amino acid mutations in the panel of NAAIRS
mutants used (32) relative to a wt hTERT sequence in
Genbank (33). We corrected these amino acids and con-
ﬁrmed that they have no effect on telomerase activity or
on any of the kinetic parameters measured in this study
(Supplementary Figure S2 and Table S1).
Mutant+170 has a defect in DNA binding afﬁnity
Since the Km for a primer-enzyme interaction (measured
by activity) is not necessarily equal to the afﬁnity constant
(Kd) for the same interaction, we next measured primer
afﬁnity directly using a pulldown assay that we had de-
veloped for Tetrahymena telomerase (11). Biotinylated
18-nt telomeric primers were incubated with puriﬁed re-
combinant enzyme and recovered with Neutravidin beads,
and the yield of telomerase measured by dot blot against
hTR (Supplementary Figure S3). The Kd of primer
binding to mutant +170 was only 2-fold greater than
that of wt telomerase (Table 3), conﬁrming that Km is
not a good measure of Kd for recombinant human
telomerase.
Since endogenous human telomerase exhibits a lower
Km than recombinant enzyme (Table 2), we also
measured direct primer binding afﬁnities for
endogenously-assembled human telomerase. We
reconstituted wt and mutant +170 telomerase in vivo in
293T cells, puriﬁed it by immunopuriﬁcation with an
hTERT antibody (40) and employed the same direct
primer binding assay. Under our transfection conditions
in 293T cells, overexpressed telomerase activity exceeds
the endogenous levels by  200-fold, resulting in <1%
contribution by the endogenous wt enzyme. To our
surprise, the Kds of primer binding of 18-nt primers to
overexpressed cellular mutant +170 were 500–1200-fold
greater than those of wt telomerase (Figure 2, Table 3).
This indicates that recombinant human telomerase does
not exactly recapitulate the DNA binding properties of
the endogenously-assembled enzyme, and this discrepancy
masks the dramatic defect in DNA binding afﬁnity of
mutant+170.
Table 3. Kd of various DNA primers with wt recombinant and overexpressed hTERT and mutant +170, and the fold difference between these
numbers
Primer Kd (nM)
Recombinant Overexpressed in 293T
wt +170 Fold
difference
wt +170 Fold
difference
Bio-18GGG 164±63 361±142 2.2 0.5±0.3 600±70 1200
Bio-18TAG n.d. n.d. 0.9±0.4 510±90 567
Bio-12GGG n.d. n.d. 0.5±0.1 1590±770 3180
Results are the mean±standard deviation of three to four experiments.
n.d., not determined.
wt
wt
+170
+170
Bio-18GGG
Bio-18TAG
[DNA]
780
390
195
98
48
24
12
hTR, amol
Bio-PBR, nM Input, 20%
5000
5000
250
250 wt +170
wt +170
Figure 2. hTERT mutant +170 has a defect in DNA binding afﬁnity.
Biotinylated telomeric primers were incubated with wt or mutant tel-
omerase reconstituted in 293T cells. The amount of telomerase re-
covered on NeutrAvidin beads was quantitated by dot blotting with
a
32P-labelled probe against hTR. The top row is a standard curve of
in vitro transcribed hTR. The middle panel represents titrations of the
indicated primers, at concentrations of 250, 50, 25, 5, 2.5, 1.25, 0.62,
0.31, 0.15nM, 78, 39 and 0 pM (wt) or 5, 2.5, 1, 0.5, 0.25mM, 50, 25, 5,
2.5, 1.25, 0.63 and 0nM (+170). On the bottom left is binding of tel-
omerase to a non-telomeric DNA control (Bio-PBR), and 20% of the
input for each experiment is shown on the bottom right. Note that all
panels are from the same exposure of a single dot blot, but are
separated for ease of labelling.
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One potential explanation for the large effect of mutation
+170 on Km, Kd and processivity is an effect on enzyme
structure. To rule this out, we fractioned wt and mutant
+170 telomerase (reconstituted in RRL) over parallel
glycerol gradients. The use of crude translation lysate
resulted in products from contaminating polymerases
and nucleases, some even more abundant than the exten-
sion products from mutant+170 (Figure 3a). Nonetheless,
telomerase extension products from both enzymes were
detected (Figure 3a, n+4 bands) and eluted with almost
identical proﬁles (Figure 3a, right panel), indicating a
similar overall composition and structure.
Another indicator of wt conformation is the ability to
bind to hTR. This was measured by immunoprecipitation
of in vitro translated hTERT with an antibody to an
N-terminal tag, followed by dot blotting to quantitate
yield of bound hTR (Figure 3b, top panel). When
normalized to the yield of
35S-labelled hTERT
(Figure 3b, bottom panel), mutant +170 bound hTR at
least as efﬁciently as wt hTERT (levels of 130±10%). To
measure the ability of mutant +170 hTERT to assemble
with hTR within human cells, we also reconstituted wt and
mutant telomerase in telomerase-negative WI38 VA13/
2RA cells (which lack endogenous expression of hTERT
and hTR). The amount of hTR that immunoprecipitated
with mutant hTERT was equal to that with wt hTERT
(Figure 3c; levels of 95±19%), demonstrating that in vivo
assembly of the telomerase complex was intact. Assembly
of mutant +170 hTERT with hTR was slightly less efﬁ-
cient in 293T cells, at 63% of wt levels (Figure 3d).
Increased Km of mutant+170 is not attributable to a
defect in translocation rate or interaction with 50-end of
primer
It has been proposed that the effect of the TEN domain on
RAP is due to a defect in the telomerase translocation step
(31). It is difﬁcult to directly measure translocation rate
with a mutant that shows almost no detectable second
repeat addition, so we instead examined the effect of
mutant +170 on translocation indirectly. In vitro
reconstituted telomerase was used to extend primer
18GGG in a reaction with
32P-dTTP as the only nucleo-
tide. This reaction results in the addition of two
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Figure 3. hTERT mutant+170 retains wt global structure. (a) wt and mutant telomerase reconstituted in rabbit reticulocyte lysates were fractionated
over parallel 10–40% glycerol gradients, and the fractions subjected to a direct telomerase assay with primer 18GGG. The ﬁgure represents two
different exposures of a single gel. LC: labelled 100nt oligonucleotide as a recovery and loading control;+4: primer plus 4nt. The relative activity in
each fraction is plotted on the right. (b) Recombinant hTERT was immunoprecipitated with a FLAG tag antibody, and the recovery of hTR
measured by dot blot with a probe against hTR (top panel). Triplicate experiments are shown (A–C). The bottom panel is an SDS–PAGE gel
showing the yield of
35S-labelled hTERT protein from each immunoprecipitate of wt or mutant +170 (m) telomerase. (c) WI38 VA13/2RA human
ﬁbroblasts were transfected with plasmids encoding hTR and wt or mutant hTERT. Telomerase was immunoprecipitated with an antibody against
hTERT. Cell lysate (L) and puriﬁed enzyme (E) were electrophoresed on a northern blot for hTR (top panel) or a western blot for hTERT (bottom
panel). (d) 293T human embryonic kidney cells were transfected with plasmids encoding hTR and wt or mutant hTERT. Telomerase was
immunoprecipitated with an antibody against hTERT and detected on a dot blot for hTR (top panel) or a western blot for hTERT (bottom panel).
Nucleic Acids Research,2011, Vol.39, No. 5 1781thymidines to the primer followed by dissociation, i.e. it
does not include the translocation step (Figure 4a; see
Figure 6a for primer-template alignment). The Km for
mutant +170 in this assay was 360±30nM and that of
wt enzyme 57±12nM, similar to that of a processive
reaction (Table 2). These data demonstrate that: (i) the
translocation rate does not contribute greatly to the
primer Km of recombinant wt telomerase and (ii) mutant
+170 retains a 6-fold defect in Km in comparison to wt,
indicating that translocation contributes at most a small
amount to its increased Km.
Crosslinking of a DNA primer to the TEN domain of
Tetrahymena TERT has been observed using primers with
photocrosslinkable substitutions at the 50-end of a 20nt
primer (11,19), suggesting that TEN binds to the primer
at an anchor site far upstream of the enzyme active site.
To determine whether the Km defect of mutant +170
reﬂects a defect in such interactions, we measured the
Km of recombinant human telomerase with shorter oligo-
nucleotide substrates. Using primer 9GGG (50-GGGTTA
GGG-30), the Km of mutant+170 was  5-fold higher than
that of wt telomerase (Table 2). The primer 5TTA (50-GG
TTA-30) was extended processively by wt telomerase but
not extended by mutant+170 (Figure 4b). Primer 5GGT
(50-AGGGT-30), which completely hybridizes with the
RNA template, was extended by wt telomerase with a
Km of  2.5mM, whereas the Km of mutant +170 with
this primer was  30mM (Figure 4c). Thus the +170
mutation results in a defect that is independent of the
presence of template-distal DNA primer sequences.
To determine whether the DNA binding defect
exhibited by overexpressed cellular +170 telomerase
(Table 3) involved binding to the 50-end of the 18nt
primers, we also measured Kd of a 12-nt oligonucleotide
(Bio-12GGG) using the direct primer pulldown assay.
Mutant +170 demonstrated an even more dramatic
defect in afﬁnity for this primer than for the 18-nt
primers, indicating that neither the Km nor Kd defects of
this mutant reﬂect interactions with the nucleotides at the
50-end of an 18-nt primer.
hTERT mutant+170 is defective in nucleotide
polymerization, particularly opposite position 51 of the
template
Since Km is a measure of total enzyme activity, it is likely
that many kinetic parameters contribute to this value. For
example, since DNA dissociation rate varies at each
template position (47), it is possible that polymerization
rate (kpol) also varies across the telomerase template; this
has not previously been tested. We therefore propose the
telomerase kinetic scheme in Figure 5, illustrated for one
round of addition of a TTAGGG repeat. The scheme
includes rate constants for association and dissociation
of primers of six permutations (e.g. kon(GGG) and
koff(GGG)), polymerization at the six positions (e.g.
kpol–1), and translocation (ktrans). The 21 rate constants
shown here, plus nucleotide association constants and
possible protein conformational changes that are not
shown, contribute to the overall Km for processive exten-
sion of a primer. In non-processive reactions including a
single dNTP, such as that in Figure 4a, the Km would
represent a portion of this scheme, illustrated by the
dashed box in Figure 5 for primer 18GGG.
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Figure 4. Increased Km of mutant+170 is not attributable to a defect in translocation rate or interaction with 50-end of primer. (a) Direct telomerase
activity assay with wt or mutant recombinant telomerase using a titration of primer 18GGG, in the presence of
32P-dTTP and no other nucleotide, in
order to measure activity in the absence of translocation. LC: labelled 100nt oligonucleotide as a recovery and loading control; +1: primer plus 1
nucleotide. (b) Activity assay in the presence or absence of primer 5TTA (50-GGTTA-30,5 0 mM), with
32P-dGTP alone (right four lanes) or
32P-dGTP, dATP and dTTP (left four lanes), using wt or mutant +170 (m) recombinant telomerase. (c) Activity assay using a titration of primer
5GGT and recombinant telomerase. LC: labelled 100nt oligonucleotide as a recovery and loading control; +3: primer plus 3nt.
1782 Nucleic Acids Research, 2011,Vol.39, No. 5To measure kpol–1 to kpol–6, we used a set of six 18-nt
primers representing the different repeat permutations, as
shown in Figure 6a. Reactions including a single
radiolabelled nucleotide were carried out at saturating
DNA and dNTP concentrations for 3h (Figure 6b),
which is within the linear range of the reaction. The reac-
tions shown in Figure 6b and Table 4 included DNA con-
centrations of 2mM; the results did not change at 5mM
primer concentration, conﬁrming that the DNA was
saturating (data not shown). The rate of these reactions
therefore represents the rate of addition of nucleotides;
since we cannot distinguish between measurement of kpol
and rates of protein conformational change (since we do
not know which is rate limiting), we have termed the
resulting rate constant kobs (Table 4). The kobs at each
position is similar for recombinant telomerase and tel-
omerase overexpressed in 293T cells; note that the units
are h
 1, demonstrating that telomerase is a slow enzyme.
For wt telomerase, kobs varies by a factor of 10–20, with
the slowest addition being at position 5 (opposite RNA
nucleotide 51, see Figure 6a) and the fastest at position 1
(opposite RNA nucleotide 49). Note that these differences
do not correlate with the  100-fold differences in enzyme
dissociation measured for these six primers (47), indicating
that primer dissociation is not rate-limiting in this
experiment.
Mutant +170 demonstrated a reduced kobs at each
template position (Figure 6b, Table 4). Most strikingly,
there was a complete lack of detectable addition to
primer 18TAG when using recombinant telomerase
(Figure 6b, top panel). This reﬂects an inability to copy
position 51 of the RNA template and thus an inability to
add the second G in the repeat TTAGGG. This was con-
ﬁrmed by the pattern of addition to primer 18TTA;
mutant+170 telomerase is able to add a single G to this
primer, but not the second G. Telomerase reconstituted in
293T cells presumably retained more contaminating nu-
cleases and polymerases after puriﬁcation, since it
produced more bands representing nuclease activity or
non-templated primer elongation (Fig. 6b, lower panel,
bands without asterisks), which complicates interpretation
of these reactions. In particular, a band of slightly slower
mobility is obscuring the extension products of primer
18TAG. Nevertheless, the trend for a reduction in kobs
for mutant+170 reﬂects that of recombinant telomerase,
and this appears to be most dramatic with primer 18TAG.
Since primers 18TTA and 18TAG can each hybridize to
two positions on the RNA template, it is theoretically
possible that they preferentially hybridize at the template
50-end. This is unlikely, since primer 18TAG displays a
monophasic dissociation rate that reﬂects binding to the
30-end of the template (47). If true, however, this would
mean that an inability to add the second G could be due to
a defect in translocation rather than a defect in addition
opposite RNA position 51. To address this, we made use
of a primer with 3nt changed such that the 30-end of the
primer can only align at the 30-end of the template (primer
18ACT; see Figure 6a, bottom). wt telomerase was able to
processively extend this primer almost as well as primer
18GGG (Figure 6c). This indicates that human telomerase
does have the ability to utilize the 30-end of its RNA
template, and thus an inability to extend primer 18TAG
likely represents a polymerization defect rather than a
translocation defect. As predicted, mutant +170 is
unable to add nucleotides to primer 18ACT.
The rate constants representing nucleotide association
are not shown in Figure 5 for simplicity, but may contrib-
ute to ﬁnal Km values. As a start towards measuring these
afﬁnities, we titrated dGTP in a non-processive reaction
using primer 18TTA (Figure 6d). The Km for dGTP of wt
recombinant telomerase was 1.3±0.4mM, while that
of mutant +170 was  3-fold higher at 4.2±1.8mM.
Figure 5. Proposed kinetic scheme for human telomerase.
(a) Alignment of an elongated 18nt DNA primer (black) with the
RNA template (red) before (top) and after (bottom) translocation
and addition of two Gs. Numbers 1–6 are assigned to each position
of nucleotide addition within a single telomeric repeat. (b) Proposed
kinetic scheme for telomerase. E=telomerase, S=DNA substrate,
with 30-permutation of each DNA primer in parenthesis.
ES=telomerase–DNA complex. It has been demonstrated that the
dissociation rate (koff) of a particular DNA sequence is the same
whether that DNA is the substrate or product of extension (47), so
only one koff has been included for each sequence. Note that the rate
constant for translocation (ktrans) is potentially composed of at least
two other rate constants, for RNA–DNA dissociation and realignment,
respectively (50). Protein conformational changes and nucleotide asso-
ciation constants are not shown in this scheme. The dashed box indi-
cates the portion of this scheme measured in a reaction with 18GGG as
the DNA primer and dTTP as the only nucleotide.
Nucleic Acids Research,2011, Vol.39, No. 5 1783Table 4. kobs using DNA primers with each of six repeat permutations, with wt recombinant and overexpressed hTERT and mutant +170
Primer Sequence kobs (h
 1)
Recombinant Overexpressed in 293T
wt +170 Fold defect wt +170 Fold defect
18GGG (TTAGGG)3 2.7±1.4 0.7±0.5 4 2.9±1.8 0.8±0.5 4
18GGT (TAGGGT)3 1.7±0.7 0.5±0.2 3 2.5±0.8 0.4±0.2 6
18GTT (AGGGTT)3 1.3±0.7 0.3±0.2 4 1.8±0.5 1.9±1.1 1
18TTA (GGGTTA)3 0.9±0.2 0.09±0.02 10 0.7±0.2 0.2±0.1 3
18TAG (GGTTAG)3 0.21±0.03 <0.006 >35 0.15±0.06 n.q. n.q.
18AGG (GTTAGG)3 0.41±0.06 0.06±0.01 7 0.34±0.09 0.15±0.12 2
Overall 0.25±0.09 0.029±0.006 9 n.d. n.d. n.d.
The rates in the ﬁrst six rows were calculated for reactions including a single radiolabelled nucleotide, i.e. non-processive reactions. The rate in the
bottom row represents a processive reaction with the primer 18GGG. Results are the mean±standard deviation of three experiments.
n.d., not determined; n.q., not quantiﬁable due to contaminating products.
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Figure 6. hTERT mutant +170 is defective in nucleotide polymerization, particularly opposite position 51 of the template. (a) Schematic of align-
ment of permuted 18nt DNA primers with the RNA template. Nucleotide position numbers of the template within hTR are shown. Primer DNA
sequence is in black uppercase; nucleotides added in reactions with a single radiolabelled nucleotide are indicated in coloured bold lower case. In
primer 18ACT, the region of mismatch with the RNA template is underlined. (b) Activity assay measuring polymerization rate at each position of the
RNA template, using recombinant telomerase (top panel) or telomerase overexpressed in 293T cells (bottom panel). Assays included the DNA
primers indicated, and a single radiolabelled nucleotide:
32P-dTTP (with 18GGG and 18GGT),
32P-dATP (with 18GTT) or
32P-dGTP (with 18TTA,
18TAG and 18AGG). Positions of templated additions of nucleotides are indicated with coloured asterisks. M=marker,
32P end labelled 18GGG
primer. (c) Extension of primer 18ACT by wild type (wt) and mutant +170 (m) recombinant telomerase, in processive (lanes 3 and 4) or
non-processive (lanes 5 and 6) reactions. LC: labelled 100nt oligonucleotide as a recovery and loading control; +1: primer plus 1nt; +4: primer
plus 4nt. (d) Titration of dGTP in a non-processive reaction with primer 18TTA. The speciﬁc activity of the
32P-dGTP was kept constant over all
dGTP concentrations. +1: primer plus 1nt.
1784 Nucleic Acids Research, 2011,Vol.39, No. 5Therefore it is possible that this mutation affects the
ability of nucleotides to enter the enzyme active site,
possibly via an allosteric interaction of the TEN domain
with the active site. However, this 3-fold defect in Km for
dGTP is insufﬁcient to explain the >35-fold defect in
addition to primer 18TAG; furthermore, the latter
reaction was carried out at a dGTP concentration of
10mM. Thus the data in Figure 6b and Table 4 point to
a defect of mutant+170 in kpol (particularly kpol–5) and/or
a defect in protein conformational changes during
catalysis.
Homology model of the human TEN domain with a
docked DNA primer
The crystal structure of the Tetrahymena TEN domain
was used to perform homology modelling of the hTERT
TEN domain using a threading technique (Figure 7b).
Although of low sequence similarity, the essential
features of the human TEN domain model and the
Tetrahymena structure are very similar; in particular, the
predicted DNA binding groove and the region mutated in
this study are highly similar (Figure 7b, red and yellow,
respectively). This model is also similar to a previously
published homology model of the human TEN domain
(48). The regions of most difference in all the models are
the poorly conserved loops (Supplementary Figure S4).
The 3nt DNA primer 50-TTA-30 was docked into the
TEN domain model using the HEX programme (42). The
top-scoring solution was positioned with its 30-end in the
pocket formed by amino acids 170–175, and showed polar
interactions with Val81, Asn95, Lys94, Tyr176 and
Gln177 (Supplementary Figure S5 and Table S2). The
DNA substrate is also positioned in a way that the
further addition of bases to the 50-end could lead to inter-
actions with residue Pro188.
During extension, the 30-end of the DNA primer is pre-
dicted to form a duplex with the RNA template. The
addition of the complementary RNA base pairs to the
docked DNA primer resulted in a steric clash between
the RNA and a large loop in the TEN domain.
However, it is plausible that this loop is sufﬁciently
ﬂexible to move out of the way, allowing interaction
with an RNA–DNA duplex (Supplementary Figure S6).
DISCUSSION
Kinetic analyses of telomerase extension using the hTERT
TEN domain mutant+170 has demonstrated that a major
defect of this mutant is in nucleotide addition opposite
position 51 of the RNA template. This mutant also
exhibits a defect in afﬁnity for an 18nt DNA primer,
corroborating previous data implicating the TEN
domain as a contributor to DNA binding afﬁnity.
However, our results demonstrate that the defect in cataly-
sis of mutant +170 is independent of its defect in DNA
binding, since catalytic rate measurements were carried
out at saturating DNA concentration. These observations
expand the numerous functions of this important region
of hTERT.
The observed catalytic defect may reﬂect a difference in
the actual polymerization rate of telomerase at this
position, or, since these amino acids are not part of the
catalytic triad of aspartates, a protein conformational
change during this step of catalysis. The latter conclusion
is supported by the ﬁnding of a possible conformational
change in the vicinity of the TEN domain in a mutant of
the nearby amino acid Q169 (30), although it should be
emphasized that we are proposing a defect in a conform-
ational change during catalysis rather than in the
steady-state conformation of the enzyme; the former
would be considerably more difﬁcult to measure.
Together with previous data demonstrating that amino
acids in this vicinity of Tetrahymena TERT have the
ability to crosslink to a DNA primer (19,28), our data
suggest that this region of the TEN domain is involved
in positioning the 30-end of the primer in the active site
(Figure 7a). Docking of the DNA primer in our human
TEN homology model supports this proposition
(Supplementary Figure S5). Conformational changes in
the enzyme are undoubtedly occurring as the RNA–
DNA duplex is realigned with the active site after
addition of each dNTP, and we propose that the TEN
domain plays a key role in mediating these. Amino acids
170–175 are particularly involved in the transition from
–TAG to –TAGG; this transition may be the one
requiring the greatest conformational change, or
possibly the other ﬁve transitions are primarily mediated
by other amino acids. The former possibility is supported
by the ﬁnding that an amino acid in a completely different
region of Tetrahymena TERT also leads to a defect in
addition of the second G in the telomeric repeat (49).
This is also the position of slowest addition (Table 4).
Mutant+170 affects nucleotide addition to some extent
at every position of the RNA template. This indicates that
these amino acids remain in the vicinity of the telomerase
active site throughout the addition cycle. Furthermore, the
DNA binding afﬁnity provided by these amino acids is
also localized to the 30-end of the primer. We postulate
that the two defects, while functionally separable, are
related in that they both result from reduced binding of
amino acids 170–175 to the 30-end of the DNA. This
region of the TEN domain is therefore not involved in
the classical ‘anchor site’ at the 50-end of the DNA
primer. In Tetrahymena TERT, amino acid W187
remains close to DNA at the 30-template boundary
throughout the addition cycle (28). Combining these two
observations results in a model whereby the distance
between these amino acids increases over the addition
cycle (Figure 7a). Since the predicted length of the
template RNA–primer DNA duplex is  27A ˚ , the
distance between W187 and Q168 in Tetrahymena TERT
is  24A ˚ , and the corresponding distance in the human
TEN model is also  24A ˚ , we propose that the structures
in Figure 7b represent the ‘stretched’ state of the TEN
domain just prior to translocation. Our model (illustrated
in Figure 7a) is a reﬁnement of previous models for the
function of the TEN domain in that we propose: (i) the
conformational change may be within the TEN domain
itself, rather than between the TEN domain and the rest of
the protein (28), and (ii) the conformational change is one
Nucleic Acids Research,2011, Vol.39, No. 5 1785occurring during nucleotide addition rather than during
translocation as previously proposed (31).
The extent of the DNA afﬁnity defect of overexpressed
cellular mutant+170 (500–1000-fold for 18-nt primers) is
the most signiﬁcant observed so far for the human tel-
omerase TEN domain (24,27,29,30,50). Interestingly, this
DNA binding defect was barely detectable using recom-
binant mutant +170 telomerase expressed in RRL. This
may explain discrepancies in the literature regarding the
extent of DNA afﬁnity contributed by this region of the
hTERT TEN domain (24,30).
DNA nucleotides 12–24nt upstream of the primer
30-end have been shown to crosslink to the Tetrahymena
TEN domain (11,19) and provide extra binding afﬁnity of
DNA to the isolated human TEN domain (24). It is there-
fore likely that other amino acids in the TEN domain
contribute to the classical telomerase ‘anchor site’ at the
50-end of the primer (13–15). The intervening nucleotides
may ‘loop-out’ during processive elongation as previously
proposed (13,14), with the TEN domain functioning to
tether the primer 50-end to the site of nucleotide addition.
DNA afﬁnity is known to be a determinant of telomer-
ase repeat addition processivity (51). In the case of
hTERT mutant +170, decreased RAP is not rescued at
high primer concentration (Supplementary Figure S1),
suggesting that the decrease in RAP is a consequence of
failure to efﬁciently copy an entire repeat, rather than due
to the DNA afﬁnity defect of this mutant. Mutation
of hTERT amino acids L13 and L14 also leads to a
decrease in RAP without a decrease in DNA afﬁnity
(31). It was proposed that the decrease in RAP of the
latter mutant is due to altered conformational changes
at the translocation step, although a speciﬁc defect in ex-
tension of primers pairing near the 30-end of the template
was also observed (31).
Previous studies on the biochemical properties of muta-
tions in the TEN domain point to a number of functions
for this region. These data, in combination with our new
results, lead us to propose that the hTERT TEN domain
comprises at least three functional domains (Figure 7b):
(i) A DNA binding groove that is essential for DNA
afﬁnity (Figure 7b, yellow, red and green). This
groove seems to be conserved between species,
since it was ﬁrst identiﬁed in the structure of the
Tetrahymena TEN domain, and can be crosslinked
to DNA primers in this species (19,28). In human
TERT, N95 has been shown to directly contribute
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Figure 7. Models of the location, structure and function of hTERT region 170–175. (a) Proposed function of hTERT amino acids 170–175 in
positioning 30-end of primer in active site. According to this model, this region of the TEN domain (yellow circle) is positioned close to the enzyme
active site (white star). As each nucleotide is added to a DNA primer ending in—TTA, the DNA–RNA duplex becomes repositioned so the new
30-end is in the active site. Depicted in red is the hTERT amino acid homologous to Tetrahymena W187; the latter has been shown to interact with a
DNA nucleotide close to the template boundary (28). See text for more detail. (b) Top: crystal structure of the TEN domain from Tetrahymena
TERT (19). The amino acids homologous to hTERT region 170–175 are shown in yellow [from sequence alignment in ref. (56)]. Amino acids
involved in crosslinking to a DNA primer (Q168, F178, W187) are red (19,28). An amino acid involved in repeat addition processivity (L14) is blue
(31). Bottom: homology model of the TEN domain of human TERT. The amino acids mutated in this study (170–175) are in yellow. Amino acids
homologous to those shown in Tetrahymena to crosslink to a primer are shown in red (Q169, P188). hTERT region 122–136 is coloured purple [part
of the ‘DAT’ domain (32)]. Amino acids involved in repeat addition processivity (L13 and L14) are blue (31). N95, shown to be involved in DNA
binding, is green (29). Figures were constructed using PYMOL (57). Note that the colours used in this ﬁgure bear no relationship to those used in
Figure 1.
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interaction with the DNA primer (Supplementary
Figure S5). Our modelling data indicate that the
30-end of the DNA is bound by the 170–175
pocket, while the 50-end of the DNA extends
towards P188 (Supplementary Figure S5).
(ii) An overlapping region that is involved speciﬁcally in
conformational changes during nucleotide addition,
the function elucidated in this study (Figure 7b,
yellow and blue). It remains possible that part of
this region (blue, L13 and L14) instead forms an
interaction with a different part of TERT that is
important during translocation (31).
(iii) A protein–protein interaction domain, part of the
previously deﬁned N-DAT domain (32), that is
involved in telomerase recruitment to the telomere
(Figure 7b, purple). Mutation of amino acids 122–
136 in hTERT impacts little on enzyme activity,
processivity, Km, or primer Kd as measured by a
direct binding assay (29, this study). Instead, there
is evidence that targeting these mutant telomerase
molecules to the telomere overcomes their defect
in vivo (52,53). The role of these amino acids in
interacting with other proteins is supported by
their location on the surface of our homology
model (Figure 7b, purple).
Other proposed functions of the hTERT TEN domain
include low-afﬁnity RNA binding that has not been
localized to particular amino acids (18,23,54,55) and a
nucleolar localization domain in a region not shared
with Tetrahymena TERT (45).
Compared to many other enzymes, telomerase has a
complicated mechanism of action that involves many
movements of the RNA template and DNA primer
relative to the enzyme’s active site. Not surprisingly, Km
is not an accurate prediction of the ﬁner mechanistic
details of telomerase. This study represents one of the
ﬁrst attempts to assign quantitative values to multiple
kinetic parameters of human telomerase. This process
has uncovered the importance of an essential N-terminal
domain of the protein in events at the enzyme’s active site.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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